Adaptive responses of the endothelium to stress

Journal of Surgical Research

Volumn 89, Issue 1, 2000, Pages 85-119

  Pohlman, Timothy H ^a   Harlan, John M ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL ACTIVATION; ENDOTHELIUM; HEAT SHOCK; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; ISCHEMIA; PHENOTYPE; PRIORITY JOURNAL; REPERFUSION INJURY; STRESS;

EID: 0034049428     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5801     Document Type: Review

References (419)

1. Cines D. B., Pollak E. S., Buck C. A., Loscalzo J., Zimmerman G. A., McEver R. P., Pober J. S., Wick T. M., Konkle B. A., Schwartz B. S., Barnathan E. S., McCrae K. R., Hug B. A., Schmidt A. M., Stern D. M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 91:1998;3527.
2. Feder M. E., Hofmann G. E. Heat-shock proteins, molecular chaperones, and the stress response: Evolutionary and ecological physiology. Annu. Rev. Physiol. 61:1999;243.
3. Morimoto R. I., Kline M. P., Bimston D. N., Cotto J. J. The heat-shock response: Regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem. 32:1997;17.
4. Gething M. J., Sambrook J. Protein folding in the cell. Nature. 355:1992;33.
5. Hartl F. U. Molecular chaperones in cellular protein folding. Nature. 381:1996;571.
6. Hightower L. E. Heat shock, stress proteins, chaperones, and proteotoxicity. Cell. 66:1991;191.
7. Sakai Y., Okamoto H., Mogami K., Matsuo H., Hotta Y. Heat shock gene activation by mutant actin is independent of myofibril degeneration in Drosophila muscle. J. Biochem. (Tokyo). 109:1991;670.
8. Straus D. B., Walter W. A., Gross C. A. Escherichia coli heat shock gene mutants are defective in proteolysis. Genes Dev. 2:1988;1851.
9. Edington B. V., Whelan S. A., Hightower L. E. Inhibition of heat shock (stress) protein induction by deuterium oxide and glycerol: Additional support for the abnormal protein hypothesis of induction. J. Cell. Physiol. 139:1989;219.
10. Plumier J. C., Ross B. M., Curriloe R. W., Angelidis C. E., Kazlaris H., Kollias G., Pagoulatos G. N. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J. Clin. Invest. 95:1995;1854.
11. Marber M. S., Mestril R., Chi S. H., Sayen M. R., Yellon D. M., Dillmann W. H. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J. Clin. Invest. 95:1995;1446.
12. DeMeester S. L., Buchman T. G., Qiu Y., Dunnigan K., Hotchkiss R. S., Karl I. E., Cobb J. P. Pyrrolidine dithiocarbamate activates the heat shock response and thereby induces apoptosis in primed endothelial cells. Shock. 10:1998;1.
13. Outinen P. A., Sood S. K., Liaw P. C., Sarge K. D., Maeda N., Hirsh J., Ribau J., Podor T. J., Weitz J. I., Austin R. C. Characterization of the stress-inducing effects of homocysteine. Biochem. J. 332:1998;213.
14. Buchman T. G., Abello P. A., Smith E. H., Bulkley G. B. Induction of heat shock response leads to apoptosis in endothelial cells previously exposed to endotoxin. Am. J. Physiol. 265:1993;H165.
15. Georgopoulos C., Welch W. J. Role of the major heat shock proteins as molecular chaperones. Annu. Rev. Cell. Biol. 9:1993;601.
16. Benjamin I. J., Kroger B., Williams R. S. Activation of the heat shock transcription factor by hypoxia in mammalian cells. Proc. Natl. Acad. Sci. USA. 87:1990;6263.
17. Mehta H. B., Popovich B. K., Dillmann W. H. Ischemia induces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M. Circ. Res. 63:1988;512.
18. Knowlton A. A., Brecher P., Apstein C. S. Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J. Clin. Invest. 87:1991;139.
19. Radford N. B., Fina M., Benjamin I. J., Moreadith R. W., Graves K. H., Zhao P., Gavva S., Wiethoff A., Sherry A. D., Malloy C. R., Williams R. S. Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;2339.
20. Hutter J. J., Mestril R., Tam E. K., Sievers R. E., Dillmann W. H., Wolfe C. L. Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation. 94:1996;1408.
21. Stokes K. Y., Abdih H. K., Kelly C. J., Redmond H. P., Bouchier-Hayes D. J. Thermotolerance attenuates ischemia-reperfusion induced renal injury and increased expression of ICAM-1. Transplantation. 62:1996;1143.
22. Wang J. H., Redmond H. P., Watson R. W., Condron C., Bouchier-Hayes D. Induction of heat shock protein 72 prevents neutrophil-mediated human endothelial cell necrosis. Arch. Surg. 130:1995;1260.
23. Chen G., Kelly C., Stokes K., Wang J. H., Leahy A., Bouchier-Hayes D. Induction of heat shock protein 72-kDa expression is associated with attenuation of ischaemia-reperfusion induced microvascular injury. J. Surg. Res. 69:1997;435.
24. Su C. Y., Chong K. Y., Owen O. E., Dillmann W. H., Chang C., Lai C. C. Constitutive and inducible hsp70s are involved in oxidative resistance evoked by heat shock or ethanol. J. Mol. Cell. Cardiol. 30:1998;587.
25. Morimoto R. I. Cells in stress: Transcriptional activation of heat shock genes. Science. 259:1993;1409.
26. Benjamin I. J., McMillan D. R. Stress (heat shock) proteins: Molecular chaperones in cardiovascular biology and disease. Circ. Res. 83:1998;117.
27. Morimoto R. I., Kroeger P. E., Cotto J. J. The transcriptional regulation of heat shock genes: A plethora of heat shock factors and regulatory conditions. EXS. 77:1996;139.
28. Wu C. Heat shock transcription factors: Structure and regulation. Annu. Rev. Cell. Dev. Biol. 11:1995;441.
29. Minowada G., Welch W. J. Clinical implications of the stress response. J. Clin. Invest. 95:1995;3.
30. Cotto J. J., Morimoto R. I. Stress-induced activation of the heat-shock response: Cell and molecular biology of heat-shock factors. Biochem. Soc. Symp. 64:1999;105.
31. Morimoto R. I., Kline M. P., Bimston D. N., Cotto J. J. The heat-shock response: Regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem. 32:1997;17.
32. Cotto J. J., Kline M., Morimoto R. I. Activation of heat shock factor 1 DNA binding precedes stress-induced serine phosphorylation. J. Biol. Chem. 271:1996;3355.
33. Mason P. B. Jr., Lis J. T. Cooperative and competitive protein interactions at the hsp70 promoter. J. Biol. Chem. 272:1997;33227.
34. Chu B., Soncin F., Price B. D., Stevenson M. A., Calderwood S. K. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1. J. Biol. Chem. 271:1996;30847.
35. Kanazawa M., Terada K., Kato S., Mori M. HSDJ, a human homolog of DnaJ, is farnesylated and is involved in protein import into mitochondria. J. Biochem. (Tokyo). 121:1997;890.
36. Takayama S., Bimston D. N., Matsuzawa S., Freeman B. C., Aime-Sempe C., Xie Z., Morimoto R. I., Reed J. C. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 16:1997;4887.
37. Zeiner M., Gebauer M., Gehring U. Mammalian protein RAP46: An interaction partner and modulator of 70 kDa heat shock proteins. EMBO J. 16:1997;5483.
38. Hohfeld J., Jentsch S. GrpE-like regulation of the hsc70 chaperone by the anti-apoptotic protein BAG-1. EMBO J. 16:1997;6209.
39. Packham G., Brimmell M., Cleveland J. L. Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem. J. 328:1997;807.
40. Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J. A., Reed J. C. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell. 80:1995;279.
41. Tschopp J., Martinon F., Hofmann K. Apoptosis: Silencing the death receptors. Curr. Biol. 9:1999;R381.
42. v-src. J. Biol. Chem. 260:1985;14292.
43. Sanchez E. R., Toft D. O., Schlesinger M. J., Pratt W. B. Evidence that the 90-kDa phosphoprotein associated with the untransformed L-cell glucocorticoid receptor is a murine heat shock protein. J. Biol. Chem. 260:1985;12398.
44. Catelli M. G., Binart N., Jung-Testas I., Renoir J. M., Baulieu E. E., Feramisco J. R., Welch W. J. The common 90-kd protein component of non-transformed '8S' steroid receptors is a heat-shock protein. EMBO J. 4:1985;3131.
45. Inanobe A., Takahashi K., Katada T. Association of the βγ subunits of trimeric GTP-binding proteins with 90-kDa heat shock protein, hsp90. J. Biochem. (Tokyo). 115:1994;486.
46. Hartson S. D., Matts R. L. Association of Hsp90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function. Biochemistry. 33:1994;8912.
47. Stancato L. F., Silverstein A. M., Owens-Grillo J. K., Chow Y. H., Jove R., Pratt W. B. The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinase. J. Biol. Chem. 272:1997;4013.
48. Dittmar K. D., Demady D. R., Stancato L. F., Krishna P., Pratt W. B. Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70. J. Biol. Chem. 272:1997;21213.
49. Stancato L. F., Chow Y. H., Hutchison K. A., Perdew G. H., Jove R., Pratt W. B. Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system. J. Biol. Chem. 268:1993;21711.
50. Pratt W. B. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu. Rev. Pharmacol. Toxicol. 37:1997;297.
51. Csermely P., Schnaider T., Soti C., Prohaszka Z., Nardai G. The 90-kDa molecular chaperone family: Structure, function, and clinical applications. Pharmacol. Ther. 79:1998;129.
52. Dunbar J. D., Song H. Y., Guo D., Wu L. W., Donner D. B. Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: Identity with subunit 2 of the 26 S protease. J. Immunol. 158:1997;4252.
53. Song H. Y., Dunbar J. D., Zhang Y. X., Guo D., Donner D. B. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J. Biol. Chem. 270:1995;3574.
54. Byrd C. A., Bornmann W., Erdjument-Bromage H., Tempst P., Pavletich N., Rosen N., Nathan C. F., Ding A. Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 96:1999;5645.
55. Obermann W. M., Sondermann H., Russo A. A., Pavletich N. P., Hartl F. U. In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. J. Cell. Biol. 143:1998;901.
56. Prodromou C., Siligardi G., O'Brien R., Woolfson D. N., Regan L., Panaretou B., Ladbury J. E., Piper P. W., Pearl L. H. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J. 18:1999;754.
57. Garcia-Cardena G., Fan R., Shah V., Sorrentino R., Cirino G., Papapetropoulos A., Sessa W. C. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 392:1998;821.
58. Shah V., Wiest R., Garcia-Cardena G., Cadelina G., Groszmann R. J., Sessa W. C. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am. J. Physiol. 277:1999;G463.
59. Stephanou A., Latchman D. S. Transcriptional regulation of the heat shock protein genes by STAT family transcription factors. Gene Expr. 7:1999;311.
60. Stephanou A., Isenberg D. A., Nakajima K., Latchman D. S. Signal transducer and activator of transcription-1 and heat shock factor-1 interact and activate the transcription of the Hsp-70 and Hsp-90β gene promoters. J. Biol. Chem. 274:1999;1723.
61. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N. Engl. J. Med. 324:1991;1149.
62. Malinow M. R., Kang S. S., Taylor L. M., Wong P. W., Coull B., Inahara T., Mukerjee D., Sexton G., Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 79:1989;1180.
63. Rodgers G. M., Kane W. H. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J. Clin. Invest. 77:1986;1909.
64. Rodgers G. M., Conn M. T. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 75:1990;895.
65. Lentz S. R., Sadler J. E. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Invest. 88:1991;1906.
66. Hayashi T., Honda G., Suzuki K. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood. 79:1992;2930.
67. Hajjar K. A. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J. Clin. Invest. 91:1993;2873.
68. 2 act synergistically to enhance mitochondrial damage. J. Biol. Chem. 273:1998;30808.
69. Rasio E. A., Bendayan M., Goresky C. A., Alexander J. S., Shepro D. Effect of phalloidin on structure and permeability of rete capillaries in the normal and hypoxic state. Circ. Res. 65:1989;591.
70. Schnittler H. J., Wilke A., Gress T., Suttorp N., Drenckhahn D. Role of actin and myosin in the control of paracellular permeability in pig, rat and human vascular endothelium. J. Physiol. (Lond). 431:1990;379.
71. Shasby D. M., Shasby S. S., Sullivan J. M., Peach M. J. Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ. Res. 51:1982;657.
72. Wong M. K., Gotlieb A. I. Endothelial cell monolayer integrity. I. Characterization of dense peripheral band of microfilaments. Arteriosclerosis. 6:1986;212.
73. Benndorf R., Hayess K., Ryazantsev S., Wieske M., Behlke J., Lutsch G. Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J. Biol. Chem. 269:1994;20780.
74. Guay J., Lambert H., Gingras-Breton G., Lavoie J. N., Huot J., Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J. Cell Sci. 110:1997;357.
75. Kato K., Hasegawa K., Goto S., Inaguma Y. Dissociation as a result of phosphorylation of an aggregated form of the small stress protein, hsp27. J. Biol. Chem. 269:1994;11274.
76. Lavoie J. N., Hickey E., Weber L. A., Landry J. Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27. J. Biol. Chem. 268:1993;24210.
77. Piotrowicz R. S., Levin E. G. Basolateral membrane-associated 27-kDa heat shock protein and microfilament polymerization. J. Biol. Chem. 272:1997;25920.
78. Loktionova S. A., Ilyinskaya O. P., Kabakov A. E. Early and delayed tolerance to simulated ischemia in heat-preconditioned endothelial cells: A role for HSP27. Am. J. Physiol. 275:1998;H2147.
79. Hinshaw D. B., Armstrong B. C., Beals T. F., Hyslop P. A. A cellular model of endothelial cell ischemia. J. Surg. Res. 44:1988;527.
80. Hinshaw D. B., Burger J. M., Miller M. T., Adams J. A., Beals T. F., Omann G. M. ATP depletion induces an increase in the assembly of a labile pool of polymerized actin in endothelial cells. Am. J. Physiol. 264:1993;C1171.
81. Kuhne W., Besselmann M., Noll T., Muhs A., Watanabe H., Piper H. M. Disintegration of cytoskeletal structure of actin filaments in energy-depleted endothelial cells. Am. J. Physiol. 264:1993;H1599.
82. Watanabe H., Kuhne W., Spahr R., Schwartz P., Piper H. M. Macromolecule permeability of coronary and aortic endothelial monolayers under energy depletion. Am. J. Physiol. 260:1991;H1344.
83. Loktionova S. A., Ilyinskaya O. P., Gabai V. L., Kabakov A. E. Distinct effects of heat shock and ATP depletion on distribution and isoform patterns of human Hsp27 in endothelial cells. FEBS Lett. 392:1996;100.
84. Huot J., Houle F., Marceau F., Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 80:1997;383.
85. Hardie D. G., Carling D., Carlson M. The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell. Annu. Rev. Biochem. 67:1998;821.
86. Hardie D. G., Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell. Eur. J. Biochem. 246:1997;259.
87. Weekes, J, Hawley, S. A, Corton, J, Shugar, D, and, Hardie, D. G. Activation of rat liver AMP-activated protein kinase by kinase kinase in a purified, reconstituted system. Effects of AMP and AMP analogues, Eur. J. Biochem. 219, 751, 1994.
88. Laufs U., Fata V. L., Liao J. K. Inhibition of 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J. Biol. Chem. 272:1997;31725.
89. Hillier S. C., Graham J. A., Hanger C. C., Godbey P. S., Glenny R. W., Wagner W. W. Jr. Hypoxic vasoconstriction in pulmonary arterioles and venules. J. Appl. Physiol. 82:1997;1084.
90. Faller D. V. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol. 26:1999;74.
91. Stempien-Otero A., Karsan A., Cornejo C. J., Xiang H., Eunson T., Morrison R. S., Kay M., Winn R., Harlan J. Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J. Biol. Chem. 274:1999;8039.
92. Sessa W. C. The nitric oxide synthase family of proteins. J. Vasc. Res. 31:1994;131.
93. Nathan C., Xie Q. W. Nitric oxide synthases: Roles, tolls, and controls. Cell. 78:1994;915.
94. Fagan K. A., Fouty B. W., Tyler R. C., Morris K. G. Jr., Hepler L. K., Sato K., LeCras T. D., Abman S. H., Weinberger H. D., Huang P. L., McMurtry I. F., Rodman D. M. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J. Clin. Invest. 103:1999;291.
95. Sase K., Michel T. Expression and regulation of endothelial nitric oxide synthase. Trends Cardiovasc. Med. 7:1997;25.
96. Michel T., Feron O. Nitric oxide synthases: which, where, how, and why. J. Clin. Invest. 100:1997;2146.
97. Harrison D. G. Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100:1997;2153.
98. Nishida K., Harrison D. G., Navas J. P., Fisher A. A., Dockery S. P., Uematsu M., Nerem R. M., Alexander R. W., Murphy T. J. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90:1992;2092.
99. Hirata K., Miki N., Kuroda Y., Sakoda T., Kawashima S., Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ. Res. 76:1995;958.
100. Sessa W. C., Pritchard K., Seyedi N., Wang J., Hintze T. H. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74:1994;349.
101. Giraldez R. R., Panda A., Xia Y., Sanders S. P., Zweier J. L. Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J. Biol. Chem. 272:1997;21420.
102. Richard V., Blanc T., Kaeffer N., Tron C., Thuillez C. Myocardial and coronary endothelial protective effects of acetylcholine after myocardial ischaemia and reperfusion in rats: Role of nitric oxide. Br. J. Pharmacol. 115:1995;1532.
103. Anderson M. E. Glutathione and glutathione delivery compounds. Adv. Pharmacol. 38:1997;65.
104. Sies H., Dafre A. L., Ji Y., Akerboom T. P. Protein S-thiolation and redox regulation of membrane-bound glutathione transferase. Chem. Biol. Interact. 111-112:1998;177.
105. Harlan J. M., Levine J. D., Callahan K. S., Schwartz B. R., Harker L. A. Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide. J. Clin. Invest. 73:1984;706.
106. Kokura S., Wolf R. E., Yoshikawa T., Granger D. N., Aw T. Y. Molecular mechanisms of neutrophil-endothelial cell adhesion induced by redox imbalance. Circ. Res. 84:1999;516.
107. Tsuchida S., Sato K. Glutathione transferases and cancer. Crit. Rev. Biochem. Mol. Biol. 27:1992;337.
108. Primiano T., Sutter T. R., Kensler T. W. Antioxidant-inducible genes. Adv. Pharmacol. 38:1997;293.
109. Jaiswal A. K. Antioxidant response element. Biochem. Pharmacol. 48:1994;439.
110. Bergelson S., Daniel V. Cooperative interaction between Ets and AP-1 transcription factors regulates induction of glutathione S-transferase Ya gene expression. Biochem. Biophys. Res. Commun. 200:1994;290.
111. Bergelson S., Pinkus R., Daniel V. Induction of AP-1 (Fos/Jun) by chemical agents mediates activation of glutathione S-transferase and quinone reductase gene expression. Oncogene. 9:1994;565.
112. Bergelson S., Pinkus R., Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res. 54:1994;36.
113. Nguyen T., Pickett C. B. Regulation of rat glutathione S-transferase Ya subunit gene expression. J. Biol. Chem. 267:1992;13535.
114. Balla J., Jacob H. S., Balla G., Nath K., Eaton J. W., Vercellotti G. M. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. USA. 90:1993;9285.
115. Maines M. D. Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2:1988;2557.
116. Applegate L. A., Luscher P., Tyrrell R. M. Induction of heme oxygenase: A general response to oxidant stress in cultured mammalian cells. Cancer Res. 51:1991;974.
117. Foresti R., Clark J. E., Green C. J., Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. J. Biol. Chem. 272:1997;18411.
118. Yee E. L., Pitt B. R., Billiar T. R., Kim Y. M. Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells. Am. J. Physiol. 271:1996;L512.
119. Terry C. M., Clikeman J. A., Hoidal J. R., Callahan K. S. Effect of tumor necrosis factor-α and interleukin-1α on heme oxygenase-1 expression in human endothelial cells. Am. J. Physiol. 274:1998;H883.
120. Motterlini R., Foresti R., Intaglietta M., Winslow R. M. NO-mediated activation of heme oxygenase: Endogenous cytoprotection against oxidative stress to endothelium. Am. J. Physiol. 270:1996;H107.
121. Juckett M., Zheng Y., Yuan H., Pastor T., Antholine W., Weber M., Vercellotti G. Heme and the endothelium. J. Biol. Chem. 273:1998;23388.
122. Khatsenko O. G., Gross S. S., Rifkind A. B., Vane J. R. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc. Natl. Acad. Sci. USA. 90:1993;11147.
123. Balla G., Vercellotti G. M., Muller-Eberhard U., Eaton J., Jacob H. S. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab. Invest. 64:1991;648.
124. Balla G., Jacob H. S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J. W., Vercellotti G. M. Ferritin: A cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267:1992;18148.
125. Wagener, Feldman E., de Witte T., Abraham N. G. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc. Soc. Exp. Biol. Med. 216:1997;456.
126. Paller M. S., Jacob H. S. Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc. Natl. Acad. Sci. USA. 91:1994;7002.
127. Vile G. F., Basu-Modak S., Waltner C., Tyrrell R. M. Heme oxygenase 1 mediates an adaptive response to oxidative stress in human skin fibroblasts. Proc. Natl. Acad. Sci. USA. 91:1994;2607.
128. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103:1999;129.
129. Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K., Yokota T., Wakasugi H. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; Possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 8:1989;757.
130. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:1997;351.
131. Yokomise H., Fukuse T., Hirata T., Ohkubo K., Go T., Muro K., Yagi K., Inui K., Hitomi S., Mitsui A. Effect of recombinant human adult T cell leukemia-derived factor on rat lung reperfusion injury. Respiration. 61:1994;99.
132. Kang S. W., Chae H. Z., Seo M. S., Kim K., Baines I. C., Rhee S. G. Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-α J. Biol. Chem. 273:1998;6297.
133. Nakamura H., Matsuda M., Furuke K., Kitaoka Y., Iwata S., Toda K., Inamoto T., Yamaoka Y., Ozawa K., Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol. Lett. 42:1994;75.
134. Shau H., Huang A. C., Faris M., Nazarian R., de Vellis J., Chen W. Thioredoxin peroxidase (natural killer enhancing factor) regulation of activator protein-1 function in endothelial cells. Biochem. Biophys. Res. Commun. 249:1998;683.
135. Abate C., Patel L., Rauscher F. J. d., Curran T. Redox regulation of fos and jun DNA-binding activity in vitro. Science. 249:1990;1157.
136. Oehler T., Pintzas A., Stumm S., Darling A., Gillespie D., Angel P. Mutation of a phosphorylation site in the DNA-binding domain is required for redox-independent transactivation of AP1-dependent genes by v-Jun. Oncogene. 8:1993;1141.
137. Nikitovic D., Holmgren A., Spyrou G. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 242:1998;109.
138. Rothwell D. G., Barzilay G., Gorman M., Morera S., Freemont P., Hickson I. D. The structure and functions of the HAP1/Ref-1 protein. Oncol. Res. 9:1997;275.
139. Dalton T. P., Shertzer H. G., Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39:1999;67.
140. Hayashi T., Ueno Y., Okamoto T. Oxidoreductive regulation of nuclear factor κB. J. Biol. Chem. 268:1993;11380.
141. Matthews J. R., Wakasugi N., Virelizier J. L., Yodoi J., Hay R. T. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:1992;3821.
142. Schenk H., Klein M., Erdbrugger W., Droge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA. 91:1994;1672.
143. 2 and antioxidants have opposite effects on activation of NF-κB and AP 1 in intact cells: AP 1 as secondary antioxidant responsive factor. EMBO J. 12:1993;2005.
144. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA. 94:1997;3633.
145. Weiss S. J. Oxygen, ischemia and inflammation. Acta Physiol. Scand. 548:1986;9.
146. Li Y., Huang T. T., Carlson E. J., Melov S., Ursell P. C., Olson J. L., Noble L. J., Yoshimura M. P., Berger C., Chan P. H. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11:1995;376.
147. Lebovitz R. M., Zhang H., Vogel H., Cartwright J. Jr., Dionne L., Lu N., Huang S., Matzuk M. M. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA. 93:1996;9782.
148. Williams M. D., Van Remmen H., Conrad C. C., Huang T. T., Epstein C. J., Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273:1998;28510.
149. Kiningham K. K., Oberley T. D., Lin S., Mattingly C. A., St Clair D. K. Overexpression of manganese superoxide dismutase protects against mitochondrial-initiated poly(ADP-ribose) polymerase-mediated cell death. FASEB J. 13:1999;1601.
150. Dimmeler S., Hermann C., Galle J., Zeiher A. M. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;656.
151. Wambi-Kiesse C. O., Katusic Z. S. Inhibition of copper/zinc superoxide dismutase impairs NO-mediated endothelium-dependent relaxations. Am. J. Physiol. 276:1999;H1043.
152. Laight D. W., Kaw A. V., Carrier M. J., Anggard E. E. Interaction between superoxide anion and nitric oxide in the regulation of vascular endothelial function. Br. J. Pharmacol. 124:1998;238.
153. Bayraktutan U., Draper N., Lang D., Shah A. M. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc. Res. 38:1998;256.
154. Yan S. D., Schmidt A. M., Anderson G. M., Zhang J., Brett J., Zou Y. S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:1994;9889.
155. Fialkow L., Chan C. K., Rotin D., Grinstein S., Downey G. P. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils. J. Biol. Chem. 269:1994;31234.
156. Staal, F. J, Anderson, M. T, Staal, G. E, Herzenberg, L. A, and, Gitler, C. Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx, Proc. Natl. Acad. Sci. USA, 91, 3619, 1994.
157. Anderson M. T., Staal F. J., Gitler C., Herzenberg L. A. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;11527.
158. Bonizzi G., Piette J., Schoonbroodt S., Greimers R., Havard L., Merville M. P., Bours V. Reactive oxygen intermediate-dependent NF-κB activation by interleukin-1β requires 5-lipoxygenase or NADPH oxidase activity. Mol. Cell. Biol. 19:1999;1950.
159. Marshall C. J. Ras effectors. Curr. Opin. Cell Biol. 8:1996;197.
160. ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270:1995;21195.
161. Deora A. A., Win T., Vanhaesebroeck B., Lander H. M. A redox-triggered Ras-effector interaction. J. Biol. Chem. 273:1998;29923.
162. Li Y. S., Shyy J. Y., Li S., Lee J., Su B., Karin M., Chien S. The Ras-JNK pathway is involved in shear-induced gene expression. Mol. Cell. Biol. 16:1996;5947.
163. Kim K. S., Takeda K., Sethi R., Pracyk J. B., Tanaka K., Zhou Y. F., Yu Z. X., Ferrans V. J., Bruder J. T., Kovesdi I., Irani K., Goldschmidt-Clermont P., Finkel T. Protection from reoxygenation injury by inhibition of rac1. J. Clin. Invest. 101:1998;1821.
164. 2-terminal kinases. J. Biol. Chem. 271:1996;15703.
165. Pombo C. M., Bonventre J. V., Avruch J., Woodgett J. R., Kyriakis J. M., Force T. The stress-activated protein kinases are major c-Jun amino-terminal kinases activated by ischemia and reperfusion. J. Biol. Chem. 269:1994;26546.
166. Knight R. J., Buxton D. B. Stimulation of c-Jun kinase and mitogen-activated protein kinase by ischemia and reperfusion in the perfused rat heart. Biochem. Biophys. Res. Commun. 218:1996;83.
167. Laderoute K. R., Webster K. A. Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ. Res. 80:1997;336.
168. Morooka H., Bonventre J. V., Pombo C. M., Kyriakis J. M., Force T. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter. J. Biol. Chem. 270:1995;30084.
169. Bogoyevitch M. A., Gillespie-Brown J., Ketterman A. J., Fuller S. J., Ben Levy R., Ashworth A., Marshall C. J., Sugden P. H. Stimulation of the stress activated mitogen activated protein kinase subfamilies in perfused heart. p38/RK mitogen activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ. Res. 79:1996;162.
170. Widmann C., Gibson S., Jarpe M. B., Johnson G. L. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143.
171. Force T., Pombo C. M., Avruch J. A., Bonventre J. V., Kyriakis J. M. Stress activated protein kinases in cardiovascular disease. Circ. Res. 78:1996;947.
172. De Luca L. G., Johnson D. R., Whitley M. Z., Collins T., Pober J. S. cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J. Biol. Chem. 269:1994;19193.
173. Kyriakis J. M., Avruch J. pp54 microtubule-associated protein 2 kinase. J. Biol. Chem. 265:1990;17355.
174. Hill C. S., Treisman R. Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell. 80:1995;199.
175. Soh J. W., Lee E. H., Prywes R., Weinstein I. B. Novel roles of specific
176. Kaszubska W., Hooft van Huijsduijnen R., Ghersa P., DeRaemy-Schenk A. M., Chen B. P., Hai T., DeLamarter J. F., Whelan J. Cyclic AMP-independent ATF family members interact with NF-κB and function in the activation of the E-selectin promoter in response to cytokines. Mol. Cell. Biol. 13:1993;7180.
177. Borden P., Heller R. A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7:1997;159.
178. Ajizian S. J., English B. K., Meals E. A. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-γ J. Infect. Dis. 179:1999;939.
179. Franchimont N., Durant D., Rydziel S., Canalis E. Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2. J. Biol. Chem. 274:1999;6783.
180. 2 and tumor necrosis factor-α induce differential binding of the redox-responsive transcription factors AP-1 and NF-κB to the interleukin-8 promoter in endothelial and epithelial cells. J. Biol. Chem. 273:1998;32670.
181. Namiki A., Brogi E., Kearney M., Kim E. A., Wu T., Couffinhal T., Varticovski L., Isner J. M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 270:1995;31189.
182. Kourembanas S., Marsden P. A., McQuillan L. P., Faller D. V. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest. 88:1991;1054.
183. Ala Y., Palluy O., Favero J., Bonne C., Modat G., Dornand J. Hypoxia/reoxygenation stimualtes endothelial cells to promote interleukin 1 and interleukin 6 production. Agents Actions. 37:1992;134.
184. Karakurum M., Shreeniwas R., Chen J., Pinsky D., Yan S. D., Anderson M., Sunouchi K., Major J., Hamilton T., Kuwabara K. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93:1994;1564.
185. Golino P., Ragni M., Cirillo P., Avvedimento V. E., Feliciello A., Esposito N., Scognamiglio A., Trimarco B., Iaccarino G., Condorelli M., Chiariello M., Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat. Med. 2:1996;35.
186. Ziesche R., Petkov V., Williams J., Zakeri S. M., Mosgoller W., Knofler M., Block L. H. Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue. Proc. Natl. Acad. Sci. USA. 93:1996;12478.
187. Schmedtje J. F. Jr., Ji Y. S., Liu W. L., DuBois R. N., Runge M. S. Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272:1997;601.
188. Zund G., Nelson D. P., Neufeld E. J., Dzus A. L., Bischoff J., Mayer J. E., Colgan S. P. Hypoxia enhances stimulus dependent induction of E selectin on aortic endothelial cells. Proc. Natl. Acad. Sci. USA. 93:1996;7075.
189. Howard E. F., Chen Q., Cheng C., Carroll J. E., Hess D. NF-κB is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells. Neurosci. Lett. 248:1998;199.
190. Collard C. D., Vakeva A., Bukusoglu C., Zund G., Sperati C. J., Colgan S. P., Stahl G. L. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway. Circulation. 96:1997;326.
191. Sauer F., Tjian R. Mechanisms of transcriptional activation: Differences and similarities between yeast. Drosophila, and man. Curr. Opin. Genet. Dev. 7:1997;176.
192. Tjian R. The biochemistry of transcription in eukaryotes: a paradigm for multisubunit regulatory complexes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351:1996;491.
193. Verrijzer C. P., Tjian R. TAFs mediate transcriptional activation and promoter selectivity. Trends Biochem. Sci. 21:1996;338.
194. Goodrich J. A., Cutler G., Tjian R. Contacts in context: Promoter specificity and macromolecular interactions in transcription. Cell. 84:1996;825.
195. Tjian R. Molecular machines that control genes. Sci. Am. 272:1995;54.
196. May M. J., Ghosh S. Rel/NF-κB and IκB proteins: an overview. Semin. Cancer. Biol. 8:1997;63.
197. Baeuerle P. A., Baltimore D. NF-κB: Ten years after. Cell. 87:1996;13.
198. Baeuerle P. A., Henkel T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:1994;141.
199. Parry G. C., Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269:1994;20823.
200. Verma I. M., Stevenson J. K., Schwarz E. M., van Antwerp D., Miyamoto S. Rel/NF-κB/IκB family: Intimate tales of association and dissociation. Genes Dev. 9:1995;2723.
201. Finco T. S., Baldwin A. S. Mechanistic aspects of NF-κB regulation: The emerging role of phosphorylation and proteolysis. Immunity. 3:1995;263.
202. Thompson J. E., Phillips R. J., Erdjument B. H., Tempst P., Ghosh S. IκBβ regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:1995;573.
203. Malinin N. L., Boldin M. P., Kovalenko A. V., Wallach D. MAP3K related kinase involved in NF-κB induction by TNF, CD95 and IL 1. Nature. 385:1997;540.
204. Song H. Y., R'Egnier C. H., Kirschning C. J., Goeddel D. V., Rothe M. Tumor necrosis factor (TNF) mediated kinase cascades: Bifurcation of nuclear factor κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor associated factor-2. Proc. Natl. Acad. Sci. USA. 94:1997;9792.
205. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of IκBα proteolysis by site specific, signal induced phosphorylation. Science. 267:1995;1485.
206. Traenckner E. B., Pahl H. L., Henkel T., Schmidt K. N., Wilk S., Baeuerle P. A. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:1995;2876.
207. Singh S., Darnay B. G., Aggarwal B. B. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation. J. Biol. Chem. 271:1996;31049.
208. Abu-Amer Y., Ross F. P., McHugh K. P., Livolsi A., Peyron J. F., Teitelbaum S. L. Tumor necrosis factor-α activation of nuclear transcription factor-κB in marrow macrophages is mediated by c-Src tyrosine phosphorylation of IκBα J. Biol. Chem. 273:1998;29417.
209. Imbert V., Rupec R. A., Livolsi A., Pahl H. L., Traenckner E. B., Mueller D. C., Farahifar D., Rossi B., Auberger P., Baeuerle P. A., Peyron J. F. Tyrosine phosphorylation of IκBβ activates NF-κB without proteolytic degradation of IκBα Cell. 86:1996;787.
210. Canty J. T. G., Boyle J. E. M., Farr A., Morgan E. N., Verrier E. D., Pohlman T. H. Oxidative stress induces NF-κB nuclear translocation without degradation of IκBα Circulation. 100:1999;II361.
211. R'Egnier C. H., Song H. Y., Gao X., Goeddel D. V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373.
212. Rosette C., Karin M. Ultraviolet light and osmotic stress: Activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 274:1996;1194.
213. Rehemtulla A., Hamilton C. A., Chinnaiyan A. M., Dixit V. M. Ultraviolet radiation induced apoptosis is mediated by activation of CD95 (Fas/APO1). J. Biol. Chem. 272:1997;25783.
214. Ogawa S., Koga S., Kuwabara K., Brett J., Morrow B., Morris S. A., Bilezikian J. P., Silverstein S. C., Stern D. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am. J. Physiol. 262:1992;C546.
215. Iyengar R. Gating by cyclic AMP: Expanded role for an old signaling pathway. Science. 271:1996;461.
216. Ghersa P., Hooft van Huijsduijnen R., Whelan J., Cambet Y., Pescini R., DeLamarter J. F. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J. Biol. Chem. 269:1994;29129.
217. Ollivier V., Houssaye S., Ternisien C., L'eon A., de Verneuil H., Elbim C., Mackman N., Edgington T. S., de Prost D. Endotoxin-induced tissue factor messenger RNA in human monocytes is negatively regulated by a cyclic AMP-dependent mechanism. Blood. 81:1993;973.
218. Ollivier V., Parry G. C. N., Cobb R. R., de Prost D., Mackman N. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J. Biol. Chem. 271:1996;20828.
219. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Gloss B., Lin S. C., Heyman R. A., Rose D. W., Glass C. K., Rosenfeld M. G. A CBP integrator complex mediates transcriptional activation and AP 1 inhibition by nuclear receptors. Cell. 85:1996;403.
220. Parry G. C., Mackman N. Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-κB-mediated transcription. J. Immunol. 159:1997;5450.
221. Pinsky D., Oz M., Liao H., Morris S., Brett J., Sciacca R., Karakurum M., Van Lookeren Campagne M., Platt J., Nowygrod R. Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model. J. Clin. Invest. 92:1993;2994.
222. Adkins W. K., Barnard J. W., May S., Seibert A. F., Haynes J., Taylor A. E. Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capillary injury. J. Appl. Physiol. 72:1992;492.
223. Wong H. R., Ryan M., Wispe J. R. Stress response decreases NF-κB nuclear translocation and increases IκBα expression in A549 cells. J. Clin. Invest. 99:1997;2423.
224. Yan S. F., Tritto I., Pinsky D., Liao H., Huang J., Fuller G., Brett J., May L., Stern D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. J. Biol. Chem. 270:1995;11463.
225. Yan S. F., Zou Y. S., Mendelsohn M., Gao Y., Naka Y., Du Yan S., Pinsky D., Stern D. Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia. J. Biol. Chem. 272:1997;4287.
226. Yan S. F., Ogawa S., Stern D. M., Pinsky D. J. Hypoxia induced modulation of endothelial cell properties: Regulation of barrier function and expression of interleukin 6. Kidney Int. 51:1997;419.
227. Kunsch C., Lang R. K., Rosen C. A., Shannon M. F. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (RelA) and NF-IL-6. J. Immunol. 153:1994;153.
228. Kukielka G. L., Smith C. W., LaRosa G. J., Manning A. M., Mendoza L. H., Daly T. J., Hughes B. J., Youker K. A., Hawkins H. K., Michael L. H. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J. Clin. Invest. 95:1995;89.
229. Oz M. C., Liao H., Naka Y., Seldomridge A., Becker D. N., Michler R. E., Smith C. R., Rose E. A., Stern D. M., Pinsky D. J. Ischemia-induced interleukin-8 release after human heart transplantation. Circulation. 92:1995.
230. Fornace A. J. Jr., Nebert D. W., Hollander M. C., Luethy J. D., Papathanasiou M., Fargnoli J., Holbrook N. J. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol. Cell. Biol. 9:1989;4196.
231. Crawford D. R., Schools G. P., Davies K. J. Oxidant-inducible adapt 15 RNA is associated with growth arrest- and DNA damage-inducible gadd153 and gadd45. Arch. Biochem. Biophys. 329:1996;137.
232. 2-resistant fibroblasts. Free Radic. Biol. Med. 20:1996;735.
233. Guyton K. Z., Xu Q., Holbrook N. J. Induction of the mammalian stress response gene GADD153 by oxidative stress: Role of AP-1 element. Biochem. J. 314:1996;547.
234. Fawcett T. W., Martindale J. L., Guyton K. Z., Hai T., Holbrook N. J. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem. J. 339:1999;135.
235. Fawcett T. W., Eastman H. B., Martindale J. L., Holbrook N. J. Physical and functional association between GADD153 and CCAAT/enhancer-binding protein β during cellular stress. J. Biol. Chem. 271:1996;14285.
236. Chen B. P., Liang G., Whelan J., Hai T. ATF3 and ATF3ΔZip. J. Biol. Chem. 269:1994;15819.
237. Ku D. N., Giddens D. P., Zarins C. K., Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Arteriosclerosis. 5:1985;293.
238. Nerem R. M., Harrison D. G., Taylor W. R., Alexander R. W. Hemodynamics and vascular endothelial biology. J. Cardiovasc. Pharmacol. 21:1993;S6.
239. Gimbrone M. A. Jr., Nagel T., Topper J. N. Biomechanical activation: An emerging paradigm in endothelial adhesion biology. J. Clin. Invest. 99:1997;1809.
240. Barbee K. A., Mundel T., Lal R., Davies P. F. Subcellular distribution of shear stress at the surface of flow-aligned and nonaligned endothelial monolayers. Am. J. Physiol. 268:1995;H1765.
241. Zhao S., Suciu A., Ziegler T., Moore J. E. Jr., Burki E., Meister J. J., Brunner H. R. Synergistic effects of fluid shear stress and cyclic circumferential stretch on vascular endothelial cell morphology and cytoskeleton. Arterioscler. Thromb. Vasc. Biol. 15:1995;1781.
242. Ziegler T., Bouzourene K., Harrison V. J., Brunner H. R., Hayoz D. Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18:1998;686.
243. Awolesi M. A., Sessa W. C., Sumpio B. E. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J. Clin. Invest. 96:1995;1449.
244. Carosi J. A., McIntire L. V. Modulation of secretion of vasoactive materials from human and bovine endothelial cells by cyclic strain. Biotechnol. Bioeng. 43:1994;615.
245. Wang D. L., Tang C. C., Wung B. S., Chen H. H., Hung M. S., Wang J. J. Cyclical strain increases endothelin-1 secretion and gene expression in human endothelial cells. Biochem. Biophys. Res. Commun. 195:1993;1050.
246. Sumpio B. E., Banes A. J. Prostacyclin synthetic activity in cultured aortic endothelial cells undergoing cyclic mechanical deformation. Surgery. 104:1988;383.
247. Iba T., Sumpio B. E. Tissue plasminogen activator expression in endothelial cells exposed to cyclic strain in vitro. Cell Transplant. 1:1992;43.
248. Du W., Mills I., Sumpio B. E. Cyclic strain causes heterogeneous induction of transcription factors, AP 1, CRE binding protein and NF-κB, in endothelial cells: Species and vascular bed diversity. J. Biomech. 28:1995;1485.
249. Mitsumata M., Fishel R. S., Nerem R. M., Alexander R. W., Berk B. C. Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. Am. J. Physiol. 265:1993;H3.
250. Davies P. F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75:1995;519.
251. Morbidelli L., Chang C. H., Douglas J. G., Granger H. J., Ledda F., Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270:1996;H411.
252. Xie Q. W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J. Exp. Med. 177:1993;1779.
253. Xie Q. W., Kashiwabara Y., Nathan C. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:1994;4705.
254. Loscalzo J., Vita J. A. Ischemia, hyperemia, exercise, and nitric oxide. Circulation. 90:1994;2556.
255. Nguyen B. L., Saitoh M., Ware J. A. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am. J. Physiol. 261:1991;H1043.
256. Rodenas J., Mitjavila M. T., Carbonell T. Nitric oxide inhibits superoxide production by inflammatory polymorphonuclear leukocytes. Am. J. Physiol. 274:1998;C827.
257. Kubes P., Suzuki M., Granger D. N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 88:1991;4651.
258. Davies P. F., Robotewskyj A., Griem M. L. Quantitative studies of endothelial cell adhesion. J. Clin. Invest. 93:1994;2031.
259. Calalb M. B., Polte T. R., Hanks S. K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: A role for Src family kinases. Mol. Cell. Biol. 15:1995;954.
260. Claesson-Welsh L., Welsh M., Ito N., Anand-Apte B., Soker S., Zetter B., O'Reilly M., Folkman J. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc. Natl. Acad. Sci. USA. 95:1998;5579.
261. Cary L. A., Guan J. L. Focal adhesion kinase in integrin-mediated signaling. Front. Biosci. 4:1999;D102.
262. Schlaepfer D. D., Hanks S. K., Hunter T., van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature. 372:1994;786.
263. Cantley L. C., Auger K. R., Carpenter C., Duckworth B., Graziani A., Kapeller R., Soltoff S. Oncogenes and signal transduction. Cell. 64:1991;281.
264. Nakanishi H., Brewer K. A., Exton J. H. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268:1993;13.
265. Hawkins P. T., Eguinoa A., Qiu R. G., Stokoe D., Cooke F. T., Walters R., Wennstrom S., Claesson-Welsh L., Evans T., Symons M. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr. Biol. 5:1995;393.
266. Turner C. E., Brown M. C., Perrotta J. A., Riedy M. C., Nikolopoulos S. N., McDonald A. R., Bagrodia S., Thomas S., Leventhal P. S. Paxillin LD4 motif binds PAK and PIX through a novel 95-kD ankyrin repeat, ARF-GAP protein: A role in cytoskeletal remodeling. J. Cell Biol. 145:1999;851.
267. FAK and microvascular endothelial barrier function. Am. J. Physiol. 275:1998;H84.
268. cas tyrosine phosphorylation in endothelial cells. Free Radic. Biol. Med. 25:1998;1021.
269. 1. Science. 269:1995;1270.
270. Leblanc V., Tocque B., Delumeau I. Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain. Mol. Cell. Biol. 18:1998;5567.
271. src-Ras-MAPK signaling pathways in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 18:1998;227.
272. βγ. J. Biol. Chem. 271:1996;12562.
273. Khachigian L. M., Resnick N., Gimbrone M. A. Jr., Collins T. Nuclear factor κB interacts functionally with the platelet derived growth factor B-chain shear stress response element in vascular endothelial cells exposed to fluid shear stress. J. Clin. Invest. 96:1995;1169.
274. Khachigian L. M., Anderson K. R., Halnon N. J., Gimbrone M. A. Jr., Resnick N., Collins T. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter. Arterioscler. Thromb. Vasc. Biol. 17:1997;2280.
275. Houston P., Dickson M. C., Ludbrook V., White B., Schwachtgen J. L., McVey J. H., Mackman N., Reese J. M., Gorman D. G., Campbell C., Braddock M. Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1. Arterioscler. Thromb. Vasc. Biol. 19:1999;281.
276. Yellon D. M., Baxter G. F., Garcia-Dorado D., Heusch G., Sumeray M. S. Ischaemic preconditioning: Present position and future directions. Cardiovasc. Res. 37:1998;21.
277. Bolli R., Manchikalapudi S., Tang X. L., Takano H., Qiu Y., Guo Y., Zhang Q., Jadoon A. K. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ. Res. 81:1997;1094.
278. Shirai T., Rao V., Weisel R. D., Ikonomidis J. S., Li R. K., Tumiati L. C., Merante F., Mickle D. A. Preconditioning human cardiomyocytes and endothelial cells. J. Thorac. Cardiovasc. Surg. 115:1998;210.
279. Kubes P., Payne D., Ostrovsky L. Preconditioning and adenosine in I/R-induced leukocyte-endothelial cell interactions. Am. J. Physiol. 274:1998;H1230.
280. Sun J. Z., Tang X. L., Knowlton A. A., Park S. W., Qiu Y., Bolli R. Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J. Clin. Invest. 95:1995;388.
281. Meldrum D. R., Cleveland J. C. Jr., Sheridan B. C., Rowland R. T., Selzman C. H., Banerjee A., Harken A. H. A adrenergic activation of myocardial NF-κB during hemorrhage. J. Surg. Res. 69:1997;268.
282. Przyklenk K., Kloner R. A. Ischemic preconditioning: Exploring the paradox. Prog. Cardiovasc. Dis. 40:1998;517.
283. Gottlieb R. A., Gruol D. L., Zhu J. Y., Engler R. L. Preconditioning rabbit cardiomyocytes: Role of pH, vacuolar proton ATPase, and apoptosis. J. Clin. Invest. 97:1996;2391.
284. Vahlhaus C., Schulz R., Post H., Rose J., Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J. Mol. Cell. Cardiol. 30:1998;197.
285. Baines C. P., Wang L., Cohen M. V., Downey J. M. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J. Mol. Cell. Cardiol. 30:1998;383.
286. Maulik N., Sato M., Price B. D., Das D. K. An essential role of NF-κB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 429:1998;365.
287. Meng X., Brown J. M., Ao L., Nordeen S. K., Franklin W., Harken A. H., Banerjee A. Endotoxin induces cardiac HSP70 and resistance to endotoxemic myocardial depression in rats. Am. J. Physiol. 271:1996;C1316.
288. 1 adrenoceptors. Cardiovasc. Res. 32:1996;374.
289. Chong K. Y., Lai C. C., Lille S., Chang C., Su C. Y. Stable overexpression of the constitutive form of heat shock protein 70 confers oxidative protection. J. Mol. Cell. Cardiol. 30:1998;599.
290. Heads R. J., Yellon D. M., Latchman D. S. Differential cytoprotection against heat stress or hypoxia following expression of specific stress protein genes in myogenic cells. J. Mol. Cell. Cardiol. 27:1995;1669.
291. Mestril R., Chi S. H., Sayen M. R., O'Reilly K., Dillmann W. H. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J. Clin. Invest. 93:1994;759.
292. Simon M. M., Reikerstorfer A., Schwarz A., Krone C., Luger T. A., Jaattela M., Schwarz T. Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. J. Clin. Invest. 95:1995;926.
293. Mosser D. D., Caron A. W., Bourget L., Denis-Larose C., Massie B. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol. Cell. Biol. 17:1997;5317.
294. Gabai V. L., Meriin A. B., Mosser D. D., Caron A. W., Rits S., Shifrin V. I., Sherman M. Y. Hsp70 prevents activation of stress kinases. J. Biol. Chem. 272:1997;18033.
295. Buzzard K. A., Giaccia A. J., Killender M., Anderson R. L. Heat shock protein 72 modulates pathways of stress-induced apoptosis. J. Biol. Chem. 273:1998;17147.
296. Muller D. W., Topol E. J., Califf R. M., Sigmon K. N., Gorman L., George B. S., Kereiakes D. J., Lee K. L., Ellis S. G. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Am. Heart J. 119:1990;224.
297. Deutsch E., Berger M., Kussmaul W. G., Hirshfeld J. W. Jr., Herrmann H. C., Laskey W. K. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation. 82:1990;2044.
298. Yellon D. M., Alkhulaifi A. M., Pugsley W. B. Preconditioning the human myocardium. Lancet. 342:1993;276.
299. Ottani F., Galvani M., Ferrini D., Sorbello F., Limonetti P., Pantoli D., Rusticali F. Prodromal angina limits infarct size. Circulation. 91:1995;291.
300. Stetler-Stevenson W. G. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J. Clin. Invest. 103:1999;1237.
301. Denekamp J. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol. 66:1993;181.
302. Gale N. W., Yancopoulos G. D. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13:1999;1055.
303. Forsythe J. A., Jiang B. H., Iyer N. V., Agani F., Leung S. W., Koos R. D., Semenza G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia inducible factor 1. Mol. Cell. Biol. 16:1996;4604.
304. Liu Y., Cox S. R., Morita T., Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ. Res. 77:1995;638.
305. Levy A. P., Levy N. S., Goldberg M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271:1996;2746.
306. 2 tension. Proc. Natl. Acad. Sci. USA. 92:1995;5510.
307. Kallio P. J., Pongratz I., Gradin K., McGuire J., Poellinger L. Activation of hypoxia-inducible factor 1α: Posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. USA. 94:1997;5667.
308. Salceda S., Caro J. Hypoxia-inducible factor-1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272:1997;22642.
309. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 95:1998;7987.
310. Huang L. E., Arany Z., Livingston D. M., Bunn H. F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J. Biol. Chem. 271:1996;32253.
311. Jiang B. H., Zheng J. Z., Leung S. W., Roe R., Semenza G. L. Transactivation and inhibitory domains of hypoxia-inducible factor 1α J. Biol. Chem. 272:1997;19253.
312. Shih S. C., Claffey K. P. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L. J. Biol. Chem. 274:1999;1359.
313. Pal S., Claffey K. P., Dvorak H. F., Mukhopadhyay D. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways. J. Biol. Chem. 272:1997;27509.
314. Cheng S. Y., Nagane M., Huang H. S., Cavenee W. K. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189. Proc. Natl. Acad. Sci. USA. 94:1997;12081.
315. Losordo D. W., Vale P. R., Symes J. F., Dunnington C. H., Esakof D. D., Maysky M., Ashare A. B., Lathi K., Isner J. M. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 98:1998;2800.
316. Schmedtje J. F. Jr., Liu W. L., Ji Y., Thompson T. M., Runge M. S. Evidence of hypoxia-inducible factor-1 in vascular endothelial and smooth muscle cells. Biochem. Biophys. Res. Commun. 220:1996;687.
317. Wang D., Huang H. J., Kazlauskas A., Cavenee W. K. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res. 59:1999;1464.
318. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N. P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell. 72:1993;835.
319. de Vries C., Escobedo J. A., Ueno H., Houck K., Ferrara N., Williams L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989.
320. Vaisman N., Gospodarowicz D., Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem. 265:1990;19461.
321. Jakeman L. B., Winer J., Bennett G. L., Altar C. A., Ferrara N. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89:1992;244.
322. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 5:1990;519.
323. Terman B. I., Dougher-Vermazen M., Carrion M. E., Dimitrov D., Armellino D. C., Gospodarowicz D., Bohlen P. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187:1992;1579.
324. Soker S., Takashima S., Miao H. Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:1998;735.
325. Kendall R. L., Thomas K. A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA. 90:1993;10705.
326. Goldman C. K., Kendall R. L., Cabrera G., Soroceanu L., Heike Y., Gillespie G. Y., Siegal G. P., Mao X., Bett A. J., Huckle W. R., Thomas K. A., Curiel D. T. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. USA. 95:1998;8795.
327. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C. H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269:1994;26988.
328. Abedi H., Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272:1997;15442.
329. Guo D., Jia Q., Song H. Y., Warren R. S., Donner D. B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. J. Biol. Chem. 270:1995;6729.
330. Xia P., Aiello L. P., Ishii H., Jiang Z. Y., Park D. J., Robinson G. S., Takagi H., Newsome W. P., Jirousek M. R., King G. L. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 98:1996;2018.
331. Seetharam L., Gotoh N., Maru Y., Neufeld G., Yamaguchi S., Shibuya M. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene. 10:1995;135.
332. Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:1997;2169.
333. Barleon B., Siemeister G., Martiny-Baron G., Weindel K., Herzog C., Marme D. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res. 57:1997;5421.
334. Shen B. Q., Lee D. Y., Gerber H. P., Keyt B. A., Ferrara N., Zioncheck T. F. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro. J. Biol. Chem. 273:1998;29979.
335. Wojta J., Kaun C., Breuss J. M., Koshelnick Y., Beckmann R., Hattey E., Mildner M., Weninger W., Nakamura T., Tschachler E., Binder B. R. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells. Lab. Invest. 79:1999;427.
336. Edelberg J. M., Aird W. C., Wu W., Rayburn H., Mamuya W. S., Mercola M., Rosenberg R. D. PDGF mediates cardiac microvascular communication. J. Clin. Invest. 102:1998;837.
337. Viglietto G., Romano A., Manzo G., Chiappetta G., Paoletti I., Califano
338. Ikeda T., Wakiya K., Shibuya M. Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor. Growth Factors. 13:1996;151.
339. Gerber H. P., Condorelli F., Park J., Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. J. Biol. Chem. 272:1997;23659.
340. Schilling L. J., Farnham P. J. Transcriptional regulation of the dihydrofolate reductase/rep-3 locus. Crit. Rev. Eukaryot. Gene Expr. 4:1994;19.
341. Maekawa R., Maki H., Yoshida H., Hojo K., Tanaka H., Wada T., Uchida N., Takeda Y., Kasai H., Okamoto H., Tsuzuki H., Kambayashi Y., Watanabe F., Kawada K., Toda K., Ohtani M., Sugita K., Yoshioka T. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res. 59:1999;1231.
342. Lozonschi L., Sunamura M., Kobari M., Egawa S., Ding L., Matsuno S. Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models. Cancer Res. 59:1999;1252.
343. Griffith E. C., Su Z., Niwayama S., Ramsay C. A., Chang Y. H., Liu J. O. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc. Natl. Acad. Sci. USA. 95:1998;15183.
344. Stack M. S., Gately S., Bafetti L. M., Enghild J. J., Soff G. A. Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem. J. 340:1999;77.
345. Cao R., Wu H. L., Veitonmaki N., Linden P., Farnebo J., Shi G. Y., Cao Y. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Proc. Natl. Acad. Sci. USA. 96:1999;5728.
346. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:1993;161.
347. Duke R. C., Ojcius D. M., Young D. J. Cell suicide in health and disease. Sci. Am. 275:1996;80.
348. Martins L. M., Earnshaw W. C. Apoptosis: Alive and kicking. Trends Cell Biol. 7:1997;111.
349. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239.
350. Nagata, S. Apoptosis by death factor, Cell, 88, 355, 1997.
351. Chinnaiyan A. M., O'Rourke K., Yu G. L., Lyons R. H., Garg M., Duan D. R., Xing L., Gentz R., Ni J., Dixit V. M. Signal transduction by DR3, a death domain containing receptor related to TNFR 1 and CD95. Science. 274:1996;990.
352. Bodmer J. L., Burns K., Schneider P., Hofmann K., Steiner V., Thome M., Bornand T., Hahne M., Schroter M., Becker K., Wilson A., French L. E., Browning J. L., MacDonald H. R., Tschopp J. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity. 6:1997;79.
353. Ashkenazi A., Dixit V. M. Death receptors: Signaling and modulation. Science. 281:1998;1305.
354. Boldin M. P., Goncharov T. M., Goltsev Y. V., Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803.
355. Chinnaiyan A. M., Tepper C. G., Seldin M. F., O'Rourke K., Kischkel F. C., Hellbardt S., Krammer P. H., Peter M. E., Dixit V. M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961.
356. Jiang Y., Woronicz J. D., Liu W., Goeddel D. V. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science. 283:1999;543.
357. Green D. R., Reed J. C. Mitochondria and apoptosis. Science. 281:1998;1309.
358. Wallace D. C. Mitochondrial diseases in man and mouse. Science. 283:1999;1482.
359. Rhodes R. S., DePalma R. G. Mitochondrial dysfunction of the liver and hypoglycemia in hemorrhagic shock. Surg. Gynecol. Obstet. 150:1980;347.
360. Nicholas G. G., Mela L. M., Miller L. D. Early alterations in mitochondrial membrane transport during endotoxemia. J. Surg. Res. 16:1974;375.
361. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132.
362. Liu X., Kim C. N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147.
363. Reed J. C. Cytochrome c: Can't live with it - can't live without it. Cell. 91:1997;559.
364. Susin S. A., Lorenzo H. K., Zamzami N., Marzo I., Snow B. E., Brothers G. M., Mangion J., Jacotot E., Costantini P., Loeffler M., Larochette N., Goodlett D. R., Aebersold R., Siderovski D. P., Penninger J. M., Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441.
365. Zou H., Henzel W. J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405.
366. Slowik M. R., Min W., Ardito T., Karsan A., Kashgarian M., Pober J. S. Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab. Invest. 77:1997;257.
367. Ledgerwood E. C., Prins J. B., Bright N. A., Johnson D. R., Wolfreys K., Pober J. S., O'Rahilly S., Bradley J. R. Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized. Lab. Invest. 78:1998;1583.
368. Ghafourifar P., Klein S. D., Schucht O., Schenk U., Pruschy M., Rocha S., Richter C. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state. J. Biol. Chem. 274:1999;6080.
369. Herr I., Wilhelm D., Bohler T., Angel P., Debatin K. M. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16:1997;6200.
370. Pober J. S. Activation and injury of endothelial cells by cytokines. Pathol. Biol. (Paris). 46:1998;159.
371. Choi K. B., Wong F., Harlan J. M., Chaudhary P. M., Hood L., Karsan A. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J. Biol. Chem. 273:1998;20185.
372. Hannun Y. A., Obeid L. M. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20:1995;73.
373. Hannun Y. A. Functions of ceramide in coordinating cellular responses to stress. Science. 274:1996;1855.
374. Salvesen G. S., Dixit V. M. Caspases: Intracellular signaling by proteolysis. Cell. 91:1997;443.
375. Schwartz S. M. Cell death and the caspase cascade. Circulation. 97:1998;227.
376. Martin S. J., Green D. R. Protease activation during apoptosis: Death by a thousand cuts. Cell. 82:1995;349.
377. FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J. Exp. Med. 187:1998;579.
378. Bombeli T., Karsan A., Tait J. F., Harlan J. M. Apoptotic vascular endothelial cells become procoagulant. Blood. 89:1997;2429.
379. Bombeli T., Schwartz B. R., Harlan J. M. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood. 93:1999;3831.
380. 1 integrin-dependent mechanism of leukocyte adherence to apoptotic cells. J. Immunol. 162:1999;4842.
381. Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1996;1331.
382. Hu X., Yee E., Harlan J. M., Wong F., Karsan A. Lipopolysaccharide induces the antiapoptotic molecules, A1 and A20, in microvascular endothelial cells. Blood. 92:1998;2759.
383. Karsan A., Yee E., Harlan J. M. Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. J. Biol. Chem. 271:1996;27201.
384. Karsan A., Yee E., Kaushansky K., Harlan J. M. Cloning of human Bcl-2 homologue: Inflammatory cytokines induce human A1 in cultured endothelial cells. Blood. 87:1996;3089.
385. Yang E., Korsmeyer S. J. Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood. 88:1996;386.
386. Uhlmann E. J., Subramanian T., Vater C. A., Lutz R., Chinnadurai G. A potent cell death activity associated with transient high level expression of BCL-2. J. Biol. Chem. 273:1998;17926.
387. Sarma V., Lin Z., Clark L., Rust B. M., Tewari M., Noelle R. J., Dixit V. M. Activation of the B cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:1995;12343.
388. Krikos A., Laherty C. D., Dixit V. M. Transcriptional activation of the tumor necrosis factor α-inducible zinc finger protein, A20, is mediated by κB elements. J. Biol. Chem. 267:1992;17971.
389. Song H. Y., Rothe M., Goeddel D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. USA. 93:1996;6721.
390. Piot C. A., Padmanaban D., Ursell P. C., Sievers R. E., Wolfe C. L. Ischemic preconditioning decreases apoptosis in rat hearts in vivo. Circulation. 96:1997;1598.
391. Wissing D., Mouritzen H., Jaattela M. TNF-induced mitochondrial changes and activation of apoptotic proteases are inhibited by A20. Free Radic. Biol. Med. 25:1998;57.
392. Natoli G., Costanzo A., Guido F., Moretti F., Bernardo A., Burgio V. L., Agresti C., Levrero M. Nuclear factor κB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J. Biol. Chem. 273:1998;31262.
393. Opipari A. W. Jr., Boguski M. S., Dixit V. M. The A20 cDNA induced by tumor necrosis factor α encodes a novel type of zinc finger protein. J. Biol. Chem. 265:1990;14705.
394. Salvesen G. S. Programmed cell death and the caspases. APMIS. 107:1999;73.
395. Fraser A. G., James C., Evan G. I., Hengartner M. O. Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr. Biol. 9:1999;292.
396. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276.
397. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J. L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L. E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190.
398. Goltsev Y. V., Kovalenko A. V., Arnold E., Varfolomeev E. E., Brodianskii V. M., Wallach D. CASH, a novel caspase homologue with death effector domains. J. Biol. Chem. 272:1997;19641.
399. Shu H. B., Halpin D. R., Goeddel D. V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity. 6:1997;751.
400. Inohara N., Koseki T., Hu Y., Chen S., Nunez G. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;10717.
401. Srinivasula S. M., Ahmad M., Ottilie S., Bullrich F., Banks S., Wang Y., Fernandes-Alnemri T., Croce C. M., Litwack G., Tomaselli K. J., Armstrong R. C., Alnemri E. S. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis. J. Biol. Chem. 272:1997;18542.
402. Hu S., Vincenz C., Ni J., Gentz R., Dixit V. M. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J. Biol. Chem. 272:1997;17255.
403. xL and initiates cell death. Proc. Natl. Acad. Sci. USA. 94:1997;11333.
404. Rasper D. M., Vaillancourt J. P., Hadano S., Houtzager V. M., Seiden I., Keen S. L., Tawa P., Xanthoudakis S., Nasir J., Martindale D., Koop B. F., Peterson E. P., Thornberry N. A., Huang J., MacPherson D. P., Black S. C., Hornung F., Lenardo M. J., Hayden M. R., Roy S., Nicholson D. W. Cell death attenuation by 'Usurpin,' a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ. 5:1998;271.
405. Baichwal V. R., Baeuerle P. A. Activate NF-κB or die. Curr. Biol. 7:1997;R94.
406. Bessho R., Matsubara K., Kubota M., Kuwakado K., Hirota H., Wakazono Y., Lin Y. W., Okuda A., Kawai M., Nishikomori R. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem. Pharmacol. 48:1994;1883.
407. Verhaegen S., McGowan A. J., Brophy A. R., Fernandes R. S., Cotter T. G. Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line. Biochem. Pharmacol. 50:1995;1021.
408. Beg A. A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782.
409. Bach F. H., Ferran C., Soares M., Wrighton C. J., Anrather J., Winkler H., Robson S. C., Hancock W. W. Modification of vascular responses in xenotransplantation: Inflammation and apoptosis. Nat. Med. 3:1997;944.
410. Wang C. Y., Guttridge D. C., Mayo M. W., Baldwin A. S. Jr. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19:1999;5923.
411. Grimm S., Bauer M. K., Baeuerle P. A., Schulze-Osthoff K. Bcl-2 down regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell. Biol. 134:1996;13.
412. Jung M., Zhang Y., Lee S., Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκBα Science. 268:1995;1619.
413. Abbadie C., Kabrun N., Bouali F., Smardova J., St'ehelin D., Vandenbunder B., Enrietto P. J. High levels of c rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell. 75:1993;899.
414. Jaffe E. A. Cell biology of endothelial cells. Hum. Pathol. 18:1987;234.
415. Baldwin A. S. Jr. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14:1996;649.
416. Thanos D., Maniatis T. NF-κB: a lesson in family values. Cell. 80:1995;529.
417. Gerritsen M. E., Williams A. J., Neish A. S., Moore S., Shi Y., Collins T. CREB binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA. 94:1997;2927.
418. Hippenstiel S., Tannert-Otto S., Vollrath N., Krull M., Just I., Aktories K., von Eichel-Streiber C., Suttorp N. Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function. Am. J. Physiol. 272:1997;L38.
419. Walsh K., Sata M. Negative regulation of inflammation by Fas ligand expression on the vascular endothelium. Trends Cardiovasc. Med. 9:1999;34.